Houston, TXNCT05123807Now EnrollingIRB Ready

Ovarian Cancer Clinical Trial in Houston, TX

Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by M.D. Anderson Cancer Center

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access ovarian cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ovarian cancer treatment provided free

Apply for This Houston Location

Check if you qualify for this ovarian cancer clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Ovarian Cancer Study in Houston

The primary objective is to estimate overall survival after secondary cytoreductive surgery and HIPEC for women with recurrent primary mucinous ovarian cancer

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

Patients must have histologically or cytologically confirmed recurrent primary mucinous ovarian cancer
Age ≥18 years
ECOG performance status ≤ 2
Prior to surgery, patients must have adequate organ and marrow function as defined below (within 30 days of registration):
absolute neutrophil count \>1,500/mcL
platelets \>100,000/mcL
total bilirubin ≤ 1.5 mg/dL
creatinine ≤ 1.5 mg/dL
AST(SGOT)/ALT(SGPT) ≤ 3 X institutional upper limit of normal
Patients must be \> 2 weeks from prior chemotherapy or radiation therapy, except for bevacizumab treatment which requires \>6 weeks
Ability to understand and the willingness to sign a written informed consent document (either directly or via a legally authorized representative)

Exclusion Criteria

Patients who are receiving concurrent investigational therapy or who have received investigational therapy within 30 days of HIPEC (investigational therapy is defined as treatment for which there is currently no regulatory authority approved indication)
Patients with mucinous tumors with pathologic confirmation of a non-gynecologic site of origin
Patients with known active CNS metastases
Patients with known hypersensitivity to any of the components of cisplatin
Patients with a prior or concurrent malignancy who natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial.
Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
Women who are pregnant or nursing women
Patients with peripheral neuropathy ≥ grade 2
History of allogenic transplant
History of prior HIPEC or intraperitoneal chemotherapy
Known bulky extra-abdominopelvic disease
Patients with hearing impairment/tinnitus ≥ grade 2

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT05123807) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ovarian Cancer Treatment Options in Houston, TX

If you're searching for ovarian cancer treatment options in Houston, TX, this clinical trial (NCT05123807) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ovarian cancer clinical trials near you to find additional studies recruiting in your area.

More Ovarian Cancer Trials in Houston, TX

See all ovarian cancer clinical trials recruiting in Houston — not just this study.

Browse Ovarian Cancer Trials in Houston →

Browse More Trials by Condition

Ovarian Cancer TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX